Lawsone
CAS 83-72-7
Lawsone (CAS 83-72-7) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 74707.30769230769 nM | 26 | - |
| - | Potency | 25012.115789473686 nM | 14 | - |
| - | MIC | 187.5 ug.mL-1 | 2 | - |
| - | EC50 | 3.53 ug.mL-1 | 1 | - |
| - | MIC | 2500000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Lawsone used for in pharmaceutical contexts?
Lawsone (CAS 83-72-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Lawsone?
No adverse-event association or SIDER side-effect rows are rendered for Lawsone in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Lawsone also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Lawsone.
What clinical phase is Lawsone in?
No phase 1-4 clinical development badge is rendered for Lawsone because the matched compound identifier rows do not contain a max-phase value.